Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Xencor Inc (NASDAQ:XNCR)

24.98
Delayed Data
As of Apr 25
 +0.44 / +1.79%
Today’s Change
10.95
Today|||52-Week Range
29.38
-5.09%
Year-to-Date
No recent news for Xencor Inc.

Today’s Trading

Previous close24.54
Today’s open24.80
Day’s range24.70 - 25.17
Volume291,369
Average volume (3 months)240,915
Market cap$1.1B
Dividend yield--
Data as of 3:59pm ET, 04/25/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-279.46%
Earnings growth (next 5 years)--
Revenue growth (last year)+215.25%
P/E ratio44.6
Price/Sales12.75
Price/Book3.64

Competitors

 Today’s
change
Today’s
% change
INSMInsmed Inc+0.78+4.23%
EBSEmergent BioSolution...+0.85+2.93%
RGENRepligen Corp-0.48-1.37%
FOLDAmicus Therapeutics ...+0.17+2.28%
Data as of 4:02pm ET, 04/25/2017

Financials

Next reporting dateMay 17, 2017
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$87.5M
Annual profit (last year)$23.6M
Net profit margin26.99%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Bassil I. Dahiyat
Vice President-Finance &
Investor Relations
John J. Kuch
Corporate headquarters
Monrovia, California

Forecasts


Search for Jobs